← Back to Search

Other

ITI-333 for Healthy Subjects

Phase 1
Recruiting
Research Sponsored by Intra-Cellular Therapies, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up predose and multiple timepoints up to 24 and 72 hours postdose on days 1 and 14, respectively
Awards & highlights

Study Summary

This trial will test a new drug on 8 healthy people to see if it's safe & effective. 6 will get the drug, 2 will get a placebo.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~predose and multiple timepoints up to 24 and 72 hours postdose on days 1 and 14, respectively
This trial's timeline: 3 weeks for screening, Varies for treatment, and predose and multiple timepoints up to 24 and 72 hours postdose on days 1 and 14, respectively for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from baseline in ECG QT interval
Change from baseline in SpO2
Change from baseline in alanine aminotransferase
+6 more

Trial Design

4Treatment groups
Experimental Treatment
Group I: Cohort 4: 6 mg ITI-333 or placebo once daily for 14 daysExperimental Treatment2 Interventions
Group II: Cohort 3: 3 mg ITI-333 or placebo once daily for 14 daysExperimental Treatment2 Interventions
Group III: Cohort 2: 1.5 mg ITI-333 or placebo once daily for 14 daysExperimental Treatment2 Interventions
Group IV: Cohort 1: 0.75 mg ITI-333 or placebo once daily for 14 daysExperimental Treatment2 Interventions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ITI-333
2020
Completed Phase 1
~50

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Intra-Cellular Therapies, Inc.Lead Sponsor
30 Previous Clinical Trials
7,499 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,488 Previous Clinical Trials
2,622,620 Total Patients Enrolled
~14 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top